guest ::
| Home > Publications database > Implications of New Understandings of Gliomas in Children and Adults with NF1: Report of a Consensus Conference. > print |
| Home > Publications database > Implications of New Understandings of Gliomas in Children and Adults with NF1: Report of a Consensus Conference. > print |
| 001 | 153719 | ||
| 005 | 20240229123048.0 | ||
| 024 | 7 | _ | |a 10.1093/neuonc/noaa036 |2 doi |
| 024 | 7 | _ | |a pmid:32055852 |2 pmid |
| 024 | 7 | _ | |a 1522-8517 |2 ISSN |
| 024 | 7 | _ | |a 1523-5866 |2 ISSN |
| 024 | 7 | _ | |a altmetric:76128462 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-00416 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Packer, Roger J |b 0 |
| 245 | _ | _ | |a Implications of New Understandings of Gliomas in Children and Adults with NF1: Report of a Consensus Conference. |
| 260 | _ | _ | |a Oxford |c 2020 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1599025846_32392 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Jun 9;22(6):773-784 |
| 520 | _ | _ | |a Gliomas are the most common primary central nervous system tumors occurring in children and adults with neurofibromatosis type I (NF1). Over the past decade, discoveries of the molecular basis of low-grade gliomas (LGGs) have led to new approaches for diagnosis and treatments. However, these new understandings have not been fully applied to the management of NF1-associated gliomas. A consensus panel consisting of experts in NF1 and gliomas was convened to review the current molecular knowledge of NF1-associated low grade 'transformed' and high-grade gliomas; insights gained from mouse models of NF1-LGGs; challenges in diagnosing and treating older patients with NF1-associated gliomas; and advances in molecular targeted treatment and potential immunologic treatment of these tumors. Next steps are recommended to advance the management and outcomes for NF1-associated gliomas. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Iavarone, Antonio |b 1 |
| 700 | 1 | _ | |a Jones, David T W |0 P:(DE-He78)551bb92841f634070997aa168d818492 |b 2 |u dkfz |
| 700 | 1 | _ | |a Blakeley, Jaishri O |b 3 |
| 700 | 1 | _ | |a Bouffet, Eric |b 4 |
| 700 | 1 | _ | |a Fisher, Michael J |b 5 |
| 700 | 1 | _ | |a Hwang, Eugene |b 6 |
| 700 | 1 | _ | |a Hawkins, Cynthia |b 7 |
| 700 | 1 | _ | |a Kilburn, Lindsay |b 8 |
| 700 | 1 | _ | |a MacDonald, Tobey |b 9 |
| 700 | 1 | _ | |a Pfister, Stefan M |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 10 |u dkfz |
| 700 | 1 | _ | |a Rood, Brian |b 11 |
| 700 | 1 | _ | |a Rodriguez, Fausto J |b 12 |
| 700 | 1 | _ | |a Tabori, Uri |b 13 |
| 700 | 1 | _ | |a Ramaswamy, Vijay |b 14 |
| 700 | 1 | _ | |a Zhu, Yuan |b 15 |
| 700 | 1 | _ | |a Fangusaro, Jason |b 16 |
| 700 | 1 | _ | |a Johnston, Stephen A |b 17 |
| 700 | 1 | _ | |a Gutmann, David H |b 18 |
| 773 | _ | _ | |a 10.1093/neuonc/noaa036 |g p. noaa036 |0 PERI:(DE-600)2094060-9 |n 6 |p 773-784 |t Neuro-Oncology |v 22 |y 2020 |x 1523-5866 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:153719 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)551bb92841f634070997aa168d818492 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEURO-ONCOLOGY : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b NEURO-ONCOLOGY : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)B360-20160331 |k B360 |l Pediatric Glioma |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B360-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|